Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Legend Biotech Ireland Limited”

3 pharma patents match "Legend Biotech Ireland Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Legend Biotech Ireland Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Legend Biotech Ireland Limited” · 30,257 patents in full index Clear search

  1. US 12421292

    Anti-DLL3 chimeric antigen receptors and uses thereof

    Legend Biotech Ireland Limited · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted

  2. US 12275788

    Single-domain antibodies against CD33 and constructs thereof

    Legend Biotech Ireland Limited · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  3. US 12097219

    Single-domain antibodies against CLL1 and constructs thereof

    Legend Biotech Ireland Limited · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.